Nicolas Pershaf, Associate

+46 10 690 04 55 +46 76 117 40 77 nicolas.pershaf@setterwalls.se

Practice areas:Intellectual property, marketing and media law / Life Sciences Languages: Swedish, English Office: Malmo Assistant: Emilia Dansäter

Profile

I mainly assist Swedish and international companies with questions regarding intellectual property and procurement.

My daily work mainly involves regulatory issues in the areas of Life Sciences, procurement and competition law.

Read more Read less

careercasesarticles

2023-,

Setterwalls

2023,

Lund University

03 Mar 2025

Setterwalls advised in connection with the Swedish Competition Authority’s investigation of suspected coordination of price levels on generic drugs

22 May 2026

The Swedish Dental and Pharmaceutical Benefits Agency proposes new regulations on applications for subsidies and the pricing of medicinal products

22 May 2026

The Swedish Government is proposing new rules to enhance controls of fraud within the agri-food chain

22 May 2026

Further reading on the new pharmaceutical inquiry

22 May 2026

Sweden’s application of the IPI measure in relation to Chinese medical devices: almost one year on

30 Mar 2026

The Swedish Government is appointing a new medical products inquiry

30 Mar 2026

The Industrial Accelerator Act – Opportunities or Challenges?

24 Nov 2025

Proposal for a new Swedish product liability act – what does it mean?

24 Jun 2025

EU restricts Chinese participation in medical device procurement

23 Jun 2025

Withdrawal of the proposed Green Claims Directive by the European Commission

22 May 2025

Significant fine upheld for unfair trading practices in the agricultural and food sector: A landmark case on the Swedish implementation of the UTP Directive

22 May 2025

EU introduces stricter rules on plastic food contact materials

24 Nov 2024

The European Court of Justice rules on the lawfulness of patent dispute settlement agreements under Article 101 TFEU

09 Sep 2024

The Swedish and Danish Competition Authorities have carried out dawn raids at companies active in the pharmaceutical sector

29 May 2024

Key takeaways for the environmental risk assessment (ERA) in the proposal for new EU pharmaceutical legislation

30 Apr 2024

European Parliament adopts new directive on Corporate Sustainability Due Diligence – Three takeaways

18 Dec 2023

The start of something bigger? First administrative fines based on the UTP Directive now imposed in Sweden

06 Dec 2023

Switch of biological medicinal products

06 Dec 2023

Proposal for new Directive and Regulation on medicinal products for human use

23 May 2023

Proposed new rules on access to sales data on medicines for human use

23 May 2023

The European Commission proposes directive to combat greenwashing

23 May 2023

Commission proposes EU pharmaceutical reform

23 Mar 2023

Proposal for a directive on new rules on environmental claims